Impact of blood culture positivity on clinical outcomes in sepsis: a prospective observational study

血培养阳性对脓毒症临床结局的影响:一项前瞻性观察研究

阅读:1

Abstract

BACKGROUND: Bacteremia is usually considered a marker for severe infection, yet the correlation between blood culture positivity and mortality in sepsis remains uncertain. This study aimed to evaluate whether blood culture positivity is associated with adverse clinical outcomes in patients with sepsis. METHODS: This prospective observational study included adult patients with sepsis admitted to a tertiary care hospital. Patients were classified into culture-positive and culture-negative groups based on blood culture results. Clinical outcomes including 30-day mortality, length of hospital stay, and vasopressor requirement were compared. Multivariable logistic and Cox regression models were used to assess the independent association of bacteremia with mortality, adjusting for age, and comorbidities. RESULTS: Of 633 patients, 41.9% (n=265) were blood culture-positive. Although culture-positive patients had higher SOFA, SAPS II scores, and procalcitonin levels, 30-day mortality was similar between groups (20.8% vs. 26.1%; p=0.12). Length of hospital stay was comparable (median 14 vs. 16 days; p=0.374), as was ICU stay duration (p=0.693). On multivariable analysis, bacteremia was not independently associated with 30-day mortality (adjusted OR 0.62, 95% CI:0.28-1.37, p=0.236). Kaplan-Meier analysis showed a non-significant trend toward higher survival in the culture-positive group (HR 1.30, 95% CI: 0.80-2.10, p=0.293). CONCLUSIONS: Although blood culture-positive sepsis was associated with higher disease severity at presentation, it did not result in increased 30-day mortality. These findings suggest that bacteremia alone does not determine sepsis outcomes, and culture-negative sepsis should be managed with equal clinical urgency.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。